News
These healthcare leaders still could perform well in the long run. Novo Nordisk has been facing several challenges that ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
3hon MSNOpinion
Opinion | RFK Jr. and the troubling link between the antivax agenda and potential money and influence
For RFK Jr. and his antivax supporters and associates, aluminum adjuvants in some required children’s vaccines appear to be ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
23h
TipRanks on MSNNovo Nordisk’s Stock Soars Amid Strategic Moves
Novo Nordisk ( ($NVO) ) has risen by 10.44%. Read on to learn why. Novo Nordisk has seen a notable 10.44% increase in its stock price over the ...
Miah’s decade-long battle to be at peace with her body – which she says is due to health concerns rather than body image – has seen her explore a rollercoaster of weightloss methods, from fad diets to ...
Explore more
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
(Reuters) -West Pharmaceutical raised its annual profit forecast and trimmed its estimates for tariff impact on Thursday, sending the medical equipment maker's shares up 24% in early trading. West ...
The 68-year-old former two-term governor, four-term attorney general and 14-year state lawmaker indicated Saturday night he ...
Roy Cooper will lead the North Carolina Democrats’ effort to win a U.S. Senate election for the first time since 2008.
21hOpinion
MedPage Today on MSNThe Rise in Adolescent Bariatric Surgery Doesn't Mean GLP-1s Have Failed
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results